Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.nbd.2016.05.015 http://scihub22266oqcxt.onion/10.1016/j.nbd.2016.05.015 C4980916!4980916!27234656     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Neurobiol+Dis 2016 ; 93 (ä): 215-25 Nephropedia Template TP {{tp|p=27234656|t=2016. Suppression of glymphatic fluid transport in a mouse model of Alzheimer?s disease |pdf=|usr=}}{{27234656}} gab.com Text Suppression of glymphatic fluid transport in a mouse model of Alzheimer s disease JO: Neurobiol Dis http://www.kidney.de/pget.php?&tw=1&pmid=27234656 #FOAvip Glymphatic transport, defined as cerebrospinal fluid (CSF) peri-arterial inflow into brain, and interstitial fluid (ISF) clearance, is reduced in the aging brain. However, it is unclear whether glymphatic transport affects the distribution of soluble A? in Alzheimer?s disease (AD). In wild type mice, we show that A?40 (fluorescently labeled A?40 or unlabeled A?40), was distributed from CSF to brain, via the peri-arterial space, and associated with neurons. In contrast, A?42 was mostly restricted to the peri-arterial space due mainly to its greater propensity to oligomerize when compared to A?40. Interestingly, pretreatment with A?40 in the CSF, but not A?42, reduced CSF transport into brain. In APP/PS1 mice, a model of AD, with and without extensive amyloid-? deposits, glymphatic transport was reduced, due to the accumulation of toxic A? species, such as soluble oligomers. CSF-derived A?40 co-localizes with existing endogenous vascular and parenchymal amyloid-? plaques, and thus, may contribute to the progression of both cerebral amyloid angiopathy and parenchymal A? accumulation. Importantly, glymphatic failure preceded significant amyloid-? deposits, and thus, may be an early biomarker of AD. By extension, restoring glymphatic inflow and ISF clearance are potential therapeutic targets to slow the onset and progression of AD. Twit Text FOAVip Suppression of glymphatic fluid transport in a mouse model of Alzheimer s disease ????Neurobiol Dis http://www.kidney.de/pget.php?&tw=1&pmid=27234656 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=27234656 #FOAvip English Wikipedia <ref>{{Cite pmid|27234656}}</ref> Suppression of glymphatic fluid transport in a mouse model of Alzheimer?s disease #MMPMID27234656 Peng W; Achariyar TM; Li B; Liao Y; Mestre H; Hitomi E; Regan S; Kasper T; Peng S; Ding F; Benveniste H; Nedergaard M; Deane R Neurobiol Dis 2016[Sep]; 93 (ä): 215-25 PMID27234656show ga Glymphatic transport, defined as cerebrospinal fluid (CSF) peri-arterial inflow into brain, and interstitial fluid (ISF) clearance, is reduced in the aging brain. However, it is unclear whether glymphatic transport affects the distribution of soluble A? in Alzheimer?s disease (AD). In wild type mice, we show that A?40 (fluorescently labeled A?40 or unlabeled A?40), was distributed from CSF to brain, via the peri-arterial space, and associated with neurons. In contrast, A?42 was mostly restricted to the peri-arterial space due mainly to its greater propensity to oligomerize when compared to A?40. Interestingly, pretreatment with A?40 in the CSF, but not A?42, reduced CSF transport into brain. In APP/PS1 mice, a model of AD, with and without extensive amyloid-? deposits, glymphatic transport was reduced, due to the accumulation of toxic A? species, such as soluble oligomers. CSF-derived A?40 co-localizes with existing endogenous vascular and parenchymal amyloid-? plaques, and thus, may contribute to the progression of both cerebral amyloid angiopathy and parenchymal A? accumulation. Importantly, glymphatic failure preceded significant amyloid-? deposits, and thus, may be an early biomarker of AD. By extension, restoring glymphatic inflow and ISF clearance are potential therapeutic targets to slow the onset and progression of AD. äSuppression of glymphatic fluid transport in a mouse model of Alzheime(epmc).pdf DeepDyve Pubget Overpricing